Understanding Dual Marijuana and Tobacco Use in Young Adults
This study is looking for 120 young adults, aged 18-25, who currently smoke both marijuana and tobacco. The goal is to better understand why young adults use both substances, which can increase health risks like cancer. You would participate in four in-person sessions where researchers will observe your reactions to marijuana and tobacco-related items and ask about your cravings. The study will measure changes in your self-reported cravings for both marijuana and tobacco up to 40 days after your last session. This research aims to help develop better ways to help young adults stop using these substances. The study's current status is unclear.
- Study design
- This is an interventional study planning to enroll 120 participants. It is not specified if it is randomized or blinded.
- What's involved
- You would complete a phone screening, an in-person baseline screening (including a urine test and breathalyzer), and three additional in-person experimental sessions. These sessions involve exposure to cues, self-report measures, and a final exit interview.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your self-reported cravings for cannabis and tobacco will be measured up to 40 days after your baseline session.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Change in self-reported cannabis cravingUp to 40 days post-baseline session
This study utilizes a structured cannabis cue exposure paradigm. During cue exposure, participants rate subjective craving on a scale from 0, "Not at all," to 10, "Extremely." Cannabis craving will be assessed following neutral cue exposure and then cannabis cue exposure. The primary outcome will be change in cannabis craving.
- Change in self-reported tobacco cravingUp to 40 days post-baseline session
This study utilizes a structured tobacco cue exposure paradigm. During cue exposure, participants rate subjective craving on a scale from 0, "Not at all," to 10, "Extremely." Tobacco craving will be assessed following neutral cue exposure and then tobacco cue exposure. The primary outcome will be change in tobacco craving.